Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Open in API
Filings indexed 553 across all filing types
Latest filing 2025-03-05 Proxy Solicitation & In…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for HLB Co., Ltd. It contains the meeting date, location, agenda items (financial statement approval, director appointments, etc.), and information regarding electronic voting. This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-05 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (HLB) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report preliminary financial results before the final audit. Since it provides key financial highlights (revenue, operating profit, net income) and explains the reasons for the change, it fits the definition of an Earnings Release (ER). FY 2024
2025-02-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as a 'Section 16' equivalent filing) where company insiders report their shareholdings or changes in ownership. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2025-01-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (FSS) in Korea. It details the share ownership and transaction history of an executive (Kim Hyun-min) of HLB Co., Ltd. This type of filing is specifically categorized as a Director's Dealing (DIRS) report, as it tracks insider share transactions and holdings.
2025-01-07 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to attend the 40th Annual General Meeting. It does not contain the full report or proxy materials themselves, but rather serves as a formal notice of a corporate action (setting a record date). Given its nature as a regulatory notification of a specific corporate event, it fits best under the general regulatory filing category.
2024-12-13 Korean
전환가액의조정 (제38회차)
Capital/Financing Update Classification · 1% confidence The document is a formal notice regarding the adjustment of the conversion price for convertible bonds (CB) due to a decline in the market price of the underlying stock. This type of filing, which details changes to capital structure instruments like convertible bonds, falls under the category of capital and financing updates. It is not a report publication announcement, but rather the specific financial event itself.
2024-12-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.